Literature DB >> 2564415

Site-restricted persistent cytomegalovirus infection after selective long-term depletion of CD4+ T lymphocytes.

S Jonjić1, W Mutter, F Weiland, M J Reddehase, U H Koszinowski.   

Abstract

We have established a murine model system for exploring the ability of a CD4 subset-deficient host to cope with cytomegalovirus infection, and reported three findings. First, an antiviral response of the CD8 subset of T lymphocytes could be not only initiated but also maintained for a long period of time despite a continued absence of the CD4 subset, whereas the production of antiviral antibody proved strictly dependent upon help provided by the CD4 subset. Second, no function in the defense against infection could be ascribed as yet to CD4-CD8- T lymphocytes, which were seen to accumulate to a new subset as a result of depletion of the CD4 subset. This newly arising subset did not substitute for CD4+ T lymphocytes in providing help to B lymphocytes, and was also not effective in controlling the spread of virus in host tissues. As long as a function of these cells in the generation and maintenance of a CD8 subset-mediated response is not disproved, caution is indicated with concern to an autonomy of the CD8 subset. Third, even though with delay, the CD8+ effector cells raised in the CD4 subset-deficient host were able of clear vital tissues from productive infection and to restrict asymptomatic, persistent infection to acinar glandular epithelial cells in salivary gland tissue.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2564415      PMCID: PMC2189231          DOI: 10.1084/jem.169.4.1199

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  44 in total

1.  Adoptive immunotherapy of murine cytomegalovirus adrenalitis in the immunocompromised host: CD4-helper-independent antiviral function of CD8-positive memory T lymphocytes derived from latently infected donors.

Authors:  M J Reddehase; S Jonjić; F Weiland; W Mutter; U H Koszinowski
Journal:  J Virol       Date:  1988-03       Impact factor: 5.103

2.  Pathogenesis of murine cytomegalovirus infection: identification of infected cells in the spleen during acute and latent infections.

Authors:  J A Mercer; C A Wiley; D H Spector
Journal:  J Virol       Date:  1988-03       Impact factor: 5.103

3.  Propagation of salivary gland virus of the mouse in tissue cultures.

Authors:  M G SMITH
Journal:  Proc Soc Exp Biol Med       Date:  1954-07

4.  Electron microscopy of murine cytomegalovirus: development of the virus in vivo and in vitro.

Authors:  G Lussier; L Berthiaume; P Payment
Journal:  Arch Gesamte Virusforsch       Date:  1974

5.  T4+ T helper cell function in vivo: differential requirement for induction of antiviral cytotoxic T-cell and antibody responses.

Authors:  R Ahmed; L D Butler; L Bhatti
Journal:  J Virol       Date:  1988-06       Impact factor: 5.103

6.  Molecular basis for cytolytic T-lymphocyte recognition of the murine cytomegalovirus immediate-early protein pp89.

Authors:  M Del Val; H Volkmer; J B Rothbard; S Jonjić; M Messerle; J Schickedanz; M J Reddehase; U H Koszinowski
Journal:  J Virol       Date:  1988-11       Impact factor: 5.103

7.  A nonstructural viral protein expressed by a recombinant vaccinia virus protects against lethal cytomegalovirus infection.

Authors:  S Jonjić; M del Val; G M Keil; M J Reddehase; U H Koszinowski
Journal:  J Virol       Date:  1988-05       Impact factor: 5.103

8.  Failure in generating hemopoietic stem cells is the primary cause of death from cytomegalovirus disease in the immunocompromised host.

Authors:  W Mutter; M J Reddehase; F W Busch; H J Bühring; U H Koszinowski
Journal:  J Exp Med       Date:  1988-05-01       Impact factor: 14.307

9.  Antigen recognition by human T cell receptor gamma-positive lymphocytes. Specific lysis of allogeneic cells after activation in mixed lymphocyte culture.

Authors:  E Ciccone; O Viale; C Bottino; D Pende; N Migone; G Casorati; G Tambussi; A Moretta; L Moretta
Journal:  J Exp Med       Date:  1988-04-01       Impact factor: 14.307

10.  Two subsets of human T lymphocytes expressing gamma/delta antigen receptor are identifiable by monoclonal antibodies directed to two distinct molecular forms of the receptor.

Authors:  C Bottino; G Tambussi; S Ferrini; E Ciccone; P Varese; M C Mingari; L Moretta; A Moretta
Journal:  J Exp Med       Date:  1988-08-01       Impact factor: 14.307

View more
  138 in total

1.  In vivo replication of recombinant murine cytomegalovirus driven by the paralogous major immediate-early promoter-enhancer of human cytomegalovirus.

Authors:  N K Grzimek; J Podlech; H P Steffens; R Holtappels; S Schmalz; M J Reddehase
Journal:  J Virol       Date:  1999-06       Impact factor: 5.103

Review 2.  Separating antiviral and GVHD activities of donor T cells prior to bone marrow transplantation.

Authors:  Catherine T Jordan; John D Roback
Journal:  Immunol Res       Date:  2004       Impact factor: 2.829

Review 3.  Modulation of host innate and adaptive immune defenses by cytomegalovirus: timing is everything.

Authors:  A Loewendorf; C A Benedict
Journal:  J Intern Med       Date:  2010-05       Impact factor: 8.989

4.  B7-mediated costimulation of CD4 T cells constrains cytomegalovirus persistence.

Authors:  Ramon Arens; Andrea Loewendorf; Min J Her; Kirsten Schneider-Ohrum; Geoffrey R Shellam; Edith Janssen; Carl F Ware; Stephen P Schoenberger; Chris A Benedict
Journal:  J Virol       Date:  2010-10-27       Impact factor: 5.103

5.  IFN-gamma action in the media of the great elastic arteries, a novel immunoprivileged site.

Authors:  A J Dal Canto; P E Swanson; A K O'Guin; S H Speck; H W Virgin
Journal:  J Clin Invest       Date:  2001-01       Impact factor: 14.808

6.  Identification of key peptide-specific CD4+ T cell responses to human cytomegalovirus: implications for tracking antiviral populations.

Authors:  G C Harcourt; T J Scriba; N Semmo; S Bounds; E Taylor; P Klenerman
Journal:  Clin Exp Immunol       Date:  2006-11       Impact factor: 4.330

7.  Recombinant mouse cytomegalovirus expressing a ligand for the NKG2D receptor is attenuated and has improved vaccine properties.

Authors:  Irena Slavuljica; Andreas Busche; Marina Babić; Maja Mitrović; Iva Gašparović; Durđica Cekinović; Elitza Markova Car; Ester Pernjak Pugel; Ana Ciković; Vanda Juranić Lisnić; William J Britt; Ulrich Koszinowski; Martin Messerle; Astrid Krmpotić; Stipan Jonjić
Journal:  J Clin Invest       Date:  2010-11-22       Impact factor: 14.808

8.  Development of a Primary Human Cell Model for the Study of Human Cytomegalovirus Replication and Spread within Salivary Epithelium.

Authors:  Kristen M Morrison; Matthew J Beucler; Emily O Campbell; Margaret A White; Rachel E Boody; Keith C Wilson; William E Miller
Journal:  J Virol       Date:  2019-01-17       Impact factor: 5.103

9.  Virus-specific CD8(+) T cell numbers are maintained during gamma-herpesvirus reactivation in CD4-deficient mice.

Authors:  P G Stevenson; G T Belz; J D Altman; P C Doherty
Journal:  Proc Natl Acad Sci U S A       Date:  1998-12-22       Impact factor: 11.205

10.  Cutting edge: murine cytomegalovirus induces a polyfunctional CD4 T cell response.

Authors:  Ramon Arens; Peng Wang; John Sidney; Andrea Loewendorf; Alessandro Sette; Stephen P Schoenberger; Bjoern Peters; Chris A Benedict
Journal:  J Immunol       Date:  2008-05-15       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.